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these papers, however, is that the normal diameters of the
studied arterial regions were unknown. Recently, it has
been shown that the diameters of peripheral arteries
increase about 20% to 25% between ages 20 and 70
years.9,10 Furthermore, the size of an artery is dependent
on both sex and body habitus. Nomograms are now avail-
able as a means of predicting normal diameters of the
femoral and popliteal arteries.9,10 The aim of this study
was to evaluate whether there is a dilating diathesis in the
peripheral arteries of patients with AAAs, when predicted
diameters are taken into account. The common femoral
and the popliteal arteries were investigated because of
their predilection for peripheral aneurysms.
MATERIAL AND METHODS
The study was performed on 183 consecutive patients
(from 1993-1998) with AAAs (158 men, 25 women; age
range, 57-78 years), before elective surgery on the
aneurysms. The reason for the operative procedure was
based on the size of, growth rate of, or abdominal pain
related to the aneurysm. Only the common femoral artery
(CFA) was measured in the beginning of the study; later,
the popliteal artery (PA) was included. In the first 99
patients, both the left and right CFA diameters were mea-
sured, and in 103 patients, both PA diameters were mea-
sured. Because no significant differences between the right
and the left sides of arterial diameters were found, the
The wall of abdominal aortic aneurysms (AAAs) shows
degradation of the extracellular matrix with disruption of
elastic fibers.1-3 Anatomical and mechanical factors are of
importance in this degenerative process. Further, inflam-
mation may disrupt the balance in the protease/antipro-
tease system, contributing to the degeneration process.
The possibility that an AAA is not only a local vascular dis-
ease in the abdominal aorta, but also a generalized process
in the vascular system has recently been emphasized by
studies that showed defect mechanical properties in the
vascular wall of distant arteries not prone to dilatation.4,5
Furthermore, the regulation of blood flow (ie, the arteri-
olar resistance function) also seems to be disturbed.6
Earlier studies have indicated a tendency of a general
dilatation of the peripheral arteries in the population of
patients with AAAs.7,8 A problem in the interpretation of
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Arterial dimensions in the lower extremities of
patients with abdominal aortic aneurysms—no
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Purpose: This study assessed whether there is a dilating diathesis in peripheral arteries of patients with abdominal aor-
tic aneurysms (AAAs).
Methods: The anteroposterior diameters of the common femoral artery (CFA) and popliteal artery (PA) were measured
in 183 consecutive patients with an AAA (158 men, 25 women; age range, 57-78 years) before elective surgery on the
AAA and compared with that of healthy age-matched control subjects. The diameter registrations were performed on
the right leg by using a noninvasive echo-tracking ultrasound scanning technique.
Results: Eight CFA aneurysms and four PA aneurysms were found in the male patients with AAAs. Of the patients with
AAAs in the CFA and in the PA who were investigated, 46% and 49%, respectively, were affected by peripheral vascu-
lar occlusive disease (PVOD). The CFA diameters in the patients with AAAs were 97.8% of those in healthy control
subjects (P = not significant [NS]). After exclusion of the CFA aneurysms, the diameters were 92.7% of those in healthy
control subjects (P = .0003). If patients with PVOD were also excluded, the CFA diameters were 95.2% of those in
healthy control subjects (P = .022). The PA diameters in the patients with AAAs were 97.8% of those in healthy con-
trol subjects (P = NS). If PA aneurysms were excluded, the diameters were 94.4% of those in healthy control subjects
(P = .0003). If patients with PVOD were also excluded, the PA diameters were 96.1% of those in healthy control sub-
jects (P = NS).
Conclusion: After excluding the few patients with AAAs who had peripheral aneurysmal disease and the patients with
PVOD, no dilating diathesis in CFAs and PAs was found. This supports the hypothesis that specific genetic, or other
factors, not present in most AAAs are responsible for the occurrence of concomitant peripheral aneurysms.
Furthermore, the generalized vascular dilating diathesis seen in some patients seems to be a specific entity that was not
necessarily affiliated with AAA disease. (J Vasc Surg 2001;34:1079-84.)
remaining patients were measured on the right side, and
only the data from the right leg arteries are reported here.
Thus, the right CFA was measured in 151 men and 24
women, and the right PA was measured in 95 men and 14
women. The CFA was measured, in a plaque-free area, at
the site of the inguinal fossa, with the patient in a supine
position by using the hip joint as a landmark. The PA was
measured, in a plaque-free area, at the site of the popliteal
fossa, with the patient in prone position. The healthy con-
trol subjects (ie, subjects without any disease and medica-
tions or obesitas [body mass index > 30], hypertension, no
history of smoking, or family history of aneurysmal dis-
ease) consisted of 39 subjects matched for age, height,
weight, and body surface area and taken from a larger
material of normal healthy individuals, in whom the nor-
mal diameters of the CFA and PA in relation to age, sex,
and body size were defined recently. From these data,
nomograms have been constructed.9,10
Arteries with local enlargement of 1.5 times or larger
in relation to the predicted normal CFA or PA diameter
were defined as aneurysms, according to the Society of
Vascular Surgery and the International Society for
Cardiovascular Surgery.11
The anteroposterior diameter was registered by using
echo-tracking ultrasound scanning equipment (Diamove,
Teltec AB, Lund, Sweden) with a 5-MHZ B-mode real-
time linear array transducer. The technique has been
described in detail.12,13 In short, two electronic markers,
each representing one tracking gate, were automatically
aligned with and locked to the luminal interfaces of the B-
mode echo image of the anterior and posterior arterial
wall. The echo-tracker measured the distance between the
walls of the vessel. The diameter was visualized longitudi-
nally in a real-time picture, and the maximum diameter per-
pendicular to the longitudinally axis was defined. The echos
from the wall were optimized, and, after locking the echo-
tracker to the inner surface of the vessel wall, the diameter
was registered. The mean of three diameter-measurements
was used. A comparison with B-mode registration of lumi-
nal diameter showed a slight overestimation of the echo-
tracking system, probably because of locking to more
intense echoes within the arterial wall than at the luminal
side of the intima.14 All measurements were carried out by
one or two experienced technicians. The intraobserver and
interobserver variability of this ultrasound scanning method
has been shown to be small, CV 5% in healthy arteries, 2
and 3% in arteries affected by aneurysmal dilatation.12,15
The investigation could not be blinded, because the
patients with an AAA were, to some extent, already known
in the laboratory.
Patients’ history of peripheral occlusive or dilating vas-
cular disease, diseases of the heart, pulmonary disease, dia-
betes mellitus, and current medication was obtained from a
questionnaire in which specific questions about family his-
tory of aneurysmal disease were also asked. Furthermore, a
review of hospital medical records was performed. Heart
disease was defined as earlier myocardial infarction, angina
pectoris, and/or bypass grafting surgery or percutaneous
transluminal coronary angioplasty. Pulmonary disease was
defined as obstructive disease, emphysema, or both.
Peripheral vascular occlusive disease was defined as earlier
peripheral vascular surgery of ischemic non-traumatic cause,
an ankle/brachial pressure index of 0.90 or less, or both.
This method has shown a sensitivity rate of 95% in detect-
ing angiogram-positive disease.16 Systemic blood pressures
were obtained, after at least 15 minutes rest, by means of a
sphygmomanometer in both arms, and the highest value
was taken as the prevailing blood pressure.
Body surface area (BSA) was calculated according to
Du Bois’ formula: 
BSAcm2 = weight0.425 × height0.725 × 71.84.
The Ethics Committee of Lund University approved
the investigation.
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Fig 1. The predicted CFA diameters in healthy control subjects.
Mean diameter of healthy subjects are 100%. *Border for
aneurysm. The white bars represent patients without PVOD, and
the shadowed bars represent patients with PVOD.
Table I. Demographic data of patients with abdominal
aortic aneurysms and healthy subjects
Patients Healthy control
with AAAs subjects
(n = 183) (n = 39)
Age (years) 70.6 (57-78) 67.8 (57-77)
Height (cm) 175.0 ± 6.2 173.0 ± 6.2
Weight (kg) 78 ± 13 76 ± 10
Systolic BP (mm Hg) 148 ± 25 140 ± 18
Diastolic BP (mm Hg) 86 ± 10 78 ± 8
BSA (m2) 1.90 ± 0.17 1.90 ± 0.13
*Mean and range shown for age; mean ± SD shown for others.
BP, Blood pressure; BSA, body surface area.
Statistics. When comparing arterial diameters, we
used analysis of covariance. In analysis between groups
within same variables, we used the Student t test or chi-
square test (nominal data). A P value less than .05 was
considered to be significant. Data are presented as the
mean (± SD), when not otherwise indicated. For 95% CIs,
diameters of healthy control subjects are classified as
100%.
RESULTS
Table I shows demographic data on the patients with
an AAA and healthy subjects. The mean size of the AAA
was 56 mm (range, 38-88 mm) and 52 mm (range, 41-72
mm) in men and women, respectively (P = not significant
[NS]). Eight aneurysms were found in the CFA (size
range, 14.9-21.2 mm), and four aneurysms were found in
the PA (size range, 12.4-13.3 mm). All aneurysms were
found in men, none in women. In Table II, concomitant
diseases in patients with an AAA in relation to sex are sum-
marized. There were no significant differences between
men and women for age, hypertension, history of smok-
ing, pulmonary disease, heart disease, peripheral vascular
occlusive-disease (PVOD), or family history of aneurysmal
disease. Inguinal hernias and peripheral aneurysms seemed
to be more frequent in men. This failed, however, to reach
statistical significance, probably because of the relatively
low prevalence.
In the total material of patients with AAAs, women
had smaller diameters than men, both in the CFA (8.54 ±
.09 mm and 10.54 ± 2.41 mm, respectively; P = .0001)
and in the PA (6.71 ± 0.91 mm and 8.41 ± 1.61 mm,
respectively; P = .0088). These differences, however, dis-
appeared when the diameters were expressed as a percent-
age of predicted normal values according to age, sex, and
body size (CFA, 94.7% [CI, 89.4%-100.1%] and 102%
[CI, 98.4%-105.7%) in women and men, respectively; P <
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.2; PA, 94.5% [CI, 87.7%-101.4%] and 100.6% [CI,
96.7%-104.6%] in women and men, respectively; P < .3).
Diameters of the common femoral artery. The
CFA diameters in patients with AAAs were 97.8% of those
of healthy subjects (CI, 92.6%-103.2%; P = NS). Fig 1
shows the CFA diameters (%) in patients with AAAs as
compared with the predicted diameters of the CFA of
healthy subjects. The line crossing the x-axis at 1.5 times
(ie, 150%) of the predicted diameters separates the
aneurysms from those with normal diameters.
Fig 2A shows that when the CFA aneurysms were
excluded from the calculations, the mean diameter was
92.7% of that of healthy subjects (CI, 88.9%-96.5%; P =
.0003). When patients with PVOD were excluded, the mean
diameter was 100% of that of healthy subjects (CI, 94.8%-
105.6%; P = NS). When both CFA aneurysms and patients
with PVOD were excluded, the mean diameter was 95.2% of
that of healthy subjects (CI, 91.2%-99.3%, P < .03).
Diameters of the popliteal artery. The PA diameters
in patients with AAAs were 97.8% of those of healthy sub-
jects (CI, 92.6%-103.2%, P = NS). Fig 3 shows the PA
diameters (%) in patients with AAAs, as compared with the
predicted diameters of the PA of healthy subjects. The line
crossing the x-axis at 1.5 times (ie, 150%) of the predicted
diameters separates the aneurysms from PAs with normal
diameters.
Fig 2B shows that when the PA aneurysms were
excluded, the mean diameter was 94.4% of that of healthy
subjects (CI, 90.2%-98.7%; P = .0003). When patients
with PVOD were excluded, the mean diameter was 98.8%
of that of healthy subjects (CI, 93.6%-104%; P = NS).
When both PA aneurysms and patients with PVOD were
excluded, the mean diameter was 96.1% of that of healthy
subjects (CI, 91.6%-100.8%, P = NS). In the CFA and in
the PA, 32% and 33% respectively, of the patients with
AAAs had PVOD.
Fig 2. Arterial dimensions in the common femoral (A) and popliteal (B) arteries. C, Arterial diameters of healthy controls; I, total num-
ber of patients with AAAs; II, patients with AAAs when peripheral aneurysms are excluded; III, patients with AAAs when PVOD is
excluded; IV, patients with AAAs when both peripheral aneurysms and PVOD are excluded. *P < .05; significance levels when the group
of patients with aneurysms are compared with control subjects.
A B
Heart disease, pulmonary disease, hypertension, dia-
betes mellitus, and history of smoking were analyzed sep-
arately for their influence on the diameters of the CFA and
PA. No significant influence was seen, with the exception
of the history of smoking, which had a significant negative
influence on PA diameter (92.3%; CI, 86.1%-99%; P =
.028).
Clinical characteristics. Sixteen of the patients with
AAAs (8.7%) had a first-degree relative with an AAA. This
group was compared with the group of patients without a
family history of AAA for CFA and PA diameter; however,
no differences were found. Only one of the men with a
peripheral aneurysm had a family history of aneurysmal dis-
ease. In Table III, the characteristics of men with AAAs and
peripheral aneurysms, as compared with those of men with-
out peripheral aneurysms, are summarized. Hypertension
was significantly more common in men with a peripheral
aneurysm than men without a peripheral aneurysm (P <
.01), but it had no influence on the diameters.
Of those patients with a peripheral aneurysm, none
had aneurysms both in the CFA and PA, but four patients
with a peripheral aneurysm had diameters higher than the
95% CI in the nonaneurymal site. Of these patients, two
had an aneurysm in the CFA and were dilated in the PA,
and two had an aneurysm in the PA and were dilated in
the CFA.
DISCUSSION
The wall of AAAs shows degradation of the extracel-
lular matrix with disruption of elastic fibers. Anatomical
and mechanical factors are important in this degenerative
process, and an added inflammatory process may disrupt
the balance of the protease/antiprotease system.17,18
Percent reports have indicated that an AAA is not only a
localized disease in the abdominal aorta, but may also be
a general defect in the vasculature with focal manifesta-
tions in the aorta. Thus, the mechanical properties of cen-
tral arteries not affected by aneurysmal disease, such as the
carotid artery, are defective.4,5 Furthermore, in more dis-
tant parts of the vasculature, such as the subcutaneous
arterioles, there are disturbances in the blood-flow regula-
tion that might be attributed to defective function of the
elastin-containing arteriolar walls.6
About 3% to 7% of the patients with AAAs are affected
by peripheral aneurysms in the femoral and popliteal arter-
ies. Little is known, however, about whether these patients
represent a specific group that is prone to a generalized
aneurysmal disease because of genetic or other factors, or
whether they represent the end stage of a pan-vascular
dilating diathesis in the general population with AAAs.19-21
The diameter of major vessels increases during life-
time, not only during the period of body growth, but also
after. Thus, the diameter of the abdominal aorta increases
about 25% between the ages of 20 and 70 years,22 whereas
smaller arteries such as the carotid, CFA, and PA seem to
increase somewhat less.9,10 The phenomenon of further
dilation is caused by degeneration and remodeling of the
arterial wall in adults.1,23 The arterial diameter is depen-
dent on age and body size. Furthermore, sex is also of
importance, with men having larger diameters than
women, even when corrected for differences in body size.
On the basis of studies of healthy subjects, it has been pos-
sible to create nomograms for the prediction of diameters
in the abdominal aorta, CFA, and PA that may be used in
the definition of pathologic dilatation or narrowing of
arteries.23-25
In the patients with AAAs, the diameters of the CFA
and PA were equal in size to those of healthy subjects.
There are, however, confounding factors that might affect
the results. The study could not be blinded, because the
patients with AAAs were, to some extent, already known
in the laboratory. Because the expected finding of the
study was a tendency toward dilatation, a bias in the data
collection may have been introduced, with larger diame-
ters in the peripheral arteries of patients with AAAs. In the
JOURNAL OF VASCULAR SURGERY
1082 Sandgren et al December 2001
Table II. Characteristics of men and women with
abdominal aortic aneurysms
Characteristic Women (n = 25) Men (n = 158)
Age (years) 72 ± 8 73 ± 7
Hypertension 18 (72%) 94 (59%)
History of smoking 16 (64%) 98 (62%)
Pulmonary disease 2 (8%) 25 (16%)
Heart disease 9 (36%) 67 (42%)
PVOD 10 (40%) 50 (32%)
Hernia inguinalis 1 (4%) 25 (16%)
Family history of AAA 4 (16%) 12 (8%)
Peripheral aneurysm 0 14 (9%)
Mean ± SD shown for age; number of patients (%) shown for others.
PVOD, Peripheral vascular occlusive disease; AAA, abdominal aortic
aneurysm.
Fig 3. The predicted popliteal artery diameters in healthy control
subjects. Mean diameter of healthy subjects is 100%. *Border for
aneurysms. The white bars represent patients without PVOD, and
the shadowed bars represent patients with PVOD.
analysis, however, no such tendency was found, making
such a bias improbable.
The frequency of peripheral aneurysm was 5% and 4%
in the CFA and the PA, respectively. Peripheral aneurysms
were included in the calculations and might have led to an
increase of the diameters in the AAA group (Figs 1 and 2).
When they were excluded, the luminal diameters of the
patients with AAAs were decreased both in the CFA and
PA (92.7% and 94.4% of predicted normal diameters,
respectively; P = .0003 and P = .0003).
The echo-tracking ultrasound scanning technique that
was used in this investigation is a means of measuring the
luminal interfaces of the B-mode image of the anterior and
posterior arterial wall, and, theoretically, atherosclerotic
narrowing of the lumen might lead to an underestimation
of the diameter. The decreased diameter may, therefore, at
least to some extent, be explained by PVOD, because one
third of the patients with AAAs were affected by PVOD.
Earlier studies of the prevalence of atherosclerosis in the
lower leg among patients with AAAs are sparse. It seems
obvious, however, that the incidence of PVOD is higher in
our study than in others. Thus, earlier papers have shown
10% to 15% PVOD in patients with AAAs.26,27 This prob-
ably reflects differing definitions rather than a true differ-
ence in prevalence of atherosclerotic disease.16 When
patients with PVOD were excluded, the differences
between the luminal diameters in patients with AAAs and
healthy control subjects disappeared in the PA, whereas a
small but significant luminal reduction was still found in
the CFA.
These results were somewhat surprising, because Ward
(1992), using ultrasound scanning and luminal diameter
measurements as in our study, instead found a dilating
CFA and PA in patients with AAAs.7 In his calculations,
however, peripheral aneurysms were not excluded; fur-
thermore, the control subjects were not a healthy group,
and few patients were analyzed. This led us, however, to
validate our data, and a separate cohort of patients with
AAAs, treated conservatively, were also studied (n = 204).
The conclusions obtained from these data were in line
with this report (unpublished observations, T.S.).
An increased thickness of the intima and media (IMT)
of the arterial wall has been found in patients with AAAs
and may be a confounding factor that might underesti-
mate the diameter.28 This was not evaluated in our study;
however, the IMT increase has been found to be quite
small and does not explain the lack of diameter increase in
the patients with AAAs.5,28
Earlier studies have shown a familiar accumulation of
AAA that may be caused by genetic disturbances in fi-
brillin genotype or changed quotient collagen/elastin.
This particular group of patients may be prone to a gener-
alized arterial dilatation or peripheral aneurysm accumula-
tion.19,20,29 In this study, we found only 8.7% of the
patients with AAAs who had a first-degree relative with an
AAA. Thus, the familiar accumulation of heredity was low.
When these patients were analyzed separately and com-
pared with the group without a family history, however,
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no differences in CFA and PA diameters were seen. No
peripheral aneurysm was found in the hereditary group.
We found 12 (6.5%) peripheral aneurysms in the
patients with AAAs. This number of peripheral aneurysms
was expected and similar to that of other studies, although
the true frequency probably is somewhat higher, because
only the right leg was investigated.30-32 An interesting
angiographic study by Callum et al (1983) in which arte-
rial luminal diameters were measured showed a clear
dilatation in the iliac artery in patients with AAAs, whereas
the peripheral arteries of the leg were practically unaf-
fected.33 The central arteries, such as the aorta and the
carotid and iliac arteries, are elastic, whereas more periph-
eral arteries such as the femoral and popliteal arteries are
muscular, with the tunica media consisting almost entirely
of smooth muscle cells. The integrity of the arterial walls
are based on the matrix components elastin and collagen,
which also determine the mechanical properties of the vas-
cular wall, whereas smooth muscle cells have the potential
to modulate wall mechanics. If an AAA is a systemic dis-
order, it may have different features in central arteries than
in peripheral arteries.
Hypertension is a well-documented risk factor for
AAAs, and it has been discussed as an important factor in
the pathogenesis, growth rate, and risk of rupture of
AAAs. In this study, hypertension was, as expected, com-
mon, but did not influence the diameters in accordance
with other investigators.34,35
In our study, 60% to 70% of the patients with AAAs
were or had been smokers. A relation between the rate of
abdominal aneurysm dilatation and smoking has been
found.36 This study could not detect any dilating tendency
in the CFAs and PAs of patients with AAAs. Rather, a ten-
dency of narrowing was found. This might be attributed
both to increased IMT and atherosclerotic manifestations
in these patients.37
In conclusion, after excluding the few patients with
AAAs who had peripheral aneurysmal disease and the
patients with PVOD, no dilating diathesis in CFAs and
PAs is found. This supports the hypothesis that specific
Table III. Characteristics in men with abdominal aortic
aneurysms and peripheral aneurysms
Men with Men without
peripheral aneurysm peripheral aneurysm
Characteristic (n = 12) (n = 144)
Age (years) 70.0 ± 2.2 73.0 ± 0.6
Hypertension 12 (86%) 82 (57%)*
History of smoking 9 (64%) 89 (62%)
Pulmonary disease 2 (14%) 24 (17%)
Heart disease 6 (43%) 63 (44%)
PVOD 6 (43%) 44 (31%)
Hernia inguinalis 3 (21%) 22 (15%)
Family history of AAA 1 (7%) 11 (8%)
Mean ± SD shown for age; number of patients (%) shown for others.
*P < .01.
PVOD, Peripheral vascular occlusive disease; AAA, abdominal aortic
aneurysm.
genetic or other factors, not present in most AAAs, are
responsible for the occurrence of concomitant peripheral
aneurysms. Furthermore, the generalized vascular dilating
diathesis seen in some patients seems to be a specific entity
that is not necessarily affiliated with AAA disease.
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